Julie Krop, Director at Aquestive Therapeutics, Inc. (AQST), sold 25,000 shares at $5.02 ($125K) on 2026-06-23, disclosed to the SEC on 2026-06-24.
Scheduled sale ($125k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| AMAG | SELL | 2017-05-02 | $46K | — | Filing → |
| AMAG | SELL | 2016-10-20 | $245K | — | Filing → |